CLASS II ONGOING Drug recall · Reported 28 Feb 2024 · FDA Enforcement Report

Fluticasone Propionate Nasal Spray USP 50mcg recalled by Apotex

Apotex is recalling Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays - net fill, distributed nationwide in the US. The recall was initiated on 9 Feb 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot number # TX5274 Exp. 09/30/2026
Quantity recalled292,752 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0326-2024
FDA event ID
93974
Recalling firm
Apotex, Weston, FL
Classification
Class II
Status
Ongoing
Recall initiated
9 Feb 2024
FDA classified
16 Feb 2024
Reported
28 Feb 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility
Drug class
Nasal Sprays

Timeline

9 Feb 2024Recall initiated by company
16 Feb 2024Classified by FDA+7 days
28 Feb 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations: potential presence of Burkholderia cepacia complex

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Fluticasone Propionate Nasal Spray USP 50mcg, 120 Metered Sprays - 16 g net fill, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9, Manufactured for: Apotex Corp Weston, FL 33326. NDC 60505-0829-1

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

CGMP Deviations: potential presence of Burkholderia cepacia complex

Which lots are affected?

Lot number # TX5274 Exp. 09/30/2026

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 1 Oct 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Apotex

All 76
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIParoxetine Extended-Release Tablets, 37.5mg recalled by ApotexParoxetine HydrochlorideApotexPotency & AssayNationwide
DrugCLASS IIPaxil CR, Paroxetine, Extended-Release Tablets, 37.5mg recalledApotexPotency & AssayNationwide
DrugCLASS IIDesmopressin Nasal Spray, USP, 10 mcg/ bottle (50 doses) recalledApotexOtherNationwide
DrugCLASS IIBrimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%* recalledBrimonidine Tartrate/timolol Maleate Ophthalmic SolutionApotexSterilityNationwide
DrugCLASS IIKetorolac Tromethamine Ophthalmic Solution recalled by ApotexKetorolac TromethamineApotexSterilityNationwide

Other Fluticasone Propionate recalls

All 10